State Street’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Hold
71,256
﹤0.01% 3866
2025
Q4
$433K Buy
71,256
+4,600
+7% +$41.9K ﹤0.01% 3713
2025
Q3
$733K Buy
66,656
+9,865
+17% +$87.4K ﹤0.01% 3580
2025
Q2
$396K Buy
56,791
+23,100
+69% +$140K ﹤0.01% 3666
2025
Q1
$121K Hold
33,691
﹤0.01% 3929
2024
Q4
$138K Buy
33,691
+6,000
+22% +$21.6K ﹤0.01% 3926
2024
Q3
$85.6K Hold
27,691
﹤0.01% 4006
2024
Q2
$50.4K Hold
27,691
﹤0.01% 4136
2024
Q1
$44K Sell
27,691
-6,000
-18% -$11.6K ﹤0.01% 4184
2023
Q4
$67K Hold
33,691
﹤0.01% 4139
2023
Q3
$82.5K Hold
33,691
﹤0.01% 4159
2023
Q2
$97.7K Hold
33,691
﹤0.01% 4246
2023
Q1
$81.9K Hold
33,691
﹤0.01% 4381
2022
Q4
$80.9K Hold
33,691
﹤0.01% 4430
2022
Q3
$91K Hold
33,691
﹤0.01% 4496
2022
Q2
$193K Sell
33,691
-98,332
-74% -$572K ﹤0.01% 4212
2022
Q1
$1.06M Buy
132,023
+4,579
+4% +$39.5K ﹤0.01% 3792
2021
Q4
$1.48M Sell
127,444
-68
-0.1% -$796 ﹤0.01% 3724
2021
Q3
$1.73M Buy
127,512
+34,449
+37% +$458K ﹤0.01% 3646
2021
Q2
$1.4M Buy
93,063
+25,341
+37% +$389K ﹤0.01% 3608
2021
Q1
$1.19M Buy
67,722
+6,209
+10% +$111K ﹤0.01% 3584
2020
Q4
$812K Sell
61,513
-1,508
-2% -$21.3K ﹤0.01% 3592
2020
Q3
$683K Buy
63,021
+7,885
+14% +$102K ﹤0.01% 3522
2020
Q2
$684K Buy
55,136
+3,667
+7% +$49.6K ﹤0.01% 3495
2020
Q1
$820K Buy
51,469
+28,404
+123% +$564K ﹤0.01% 3352
2019
Q4
$586K Buy
+23,065
New +$410K ﹤0.01% 3497

Other funds holding XGN

State Street's XGN Position: Q1 2026 in Review

State Street held its Exagen (XGN) position steady in Q1 2026 at 71,256 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #3866.

State Street first reported a position in XGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.73M in Q3 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • State Street held 71,256 shares of Exagen worth $214K as of Q1 2026.
  • State Street left its Exagen share count unchanged in Q1 2026.
  • Exagen made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3866 holding.
  • State Street first reported a position in Exagen in Q4 2019 and has held it in 26 quarters since.
  • State Street's Exagen position peaked at $1.73M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.